Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Targeting the tRNA m1A modifier TRMT6 for colorectal cancer therapy

tRNA modifications are key regulators of translational reprogramming, although their role in colorectal cancer (CRC) is poorly understood. We show an oncogenic role for TRMT6 in CRC, revealing that TRMT6-mediated tRNA m1A modification functions as a critical translational checkpoint that is essential for rapid histone synthesis in CRC cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: TRMT6-mediated tRNA m1A modification in CRC.

References

  1. Wang, Y. et al. tRNA modifications: insights into their role in human cancers. Trends Cell Biol. 33, 1035–1048 (2023). This review article describes the roles of various tRNA modifications in human cancers.

    Article  CAS  PubMed  Google Scholar 

  2. Dekker, E. et al. Colorectal cancer. Lancet 394, 1467–1480 (2019). This review article provides a comprehensive overview of CRC, including treatment strategies.

    Article  PubMed  Google Scholar 

  3. Liu, F. et al. ALKBH1-mediated tRNA demethylation regulates translation. Cell 167, 816–828.e816 (2016). This paper reports that m1A is a reversible tRNA modification and is involved in translational reprogramming.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Liu, Y. et al. tRNA-m(1)A modification promotes T cell expansion via efficient MYC protein synthesis. Nat. Immunol. 23, 1433–1444 (2022). This paper reports that tRNA m1A modification serves as a ‘gas pedal’ for T cell expansion.

    Article  CAS  PubMed  Google Scholar 

  5. Marzluff, W. F. et al. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 9, 843–854 (2008). This review article discusses how canonical histone proteins are encoded by replication-dependent genes and must be rapidly expressed at high levels during S phase.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Tao, E.-W. et al. TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. Nat. Cancer https://doi.org/10.1038/s43018-025-00977-4 (2025).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Targeting the tRNA m1A modifier TRMT6 for colorectal cancer therapy. Nat Cancer 6, 1307–1308 (2025). https://doi.org/10.1038/s43018-025-00978-3

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s43018-025-00978-3

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer